Related Experiment Video
Updated: Aug 2, 2025

10:35
Stereotactic Radiosurgery for Gynecologic Cancer
Published on: April 17, 2012
18.2K
Radiotherapy of skin adnexal carcinoma
A Larnaudie1, P Giraud2, C Naessens3
1Department of Radiation Oncology, centre François-Baclesse, 3, avenue du Général-Harris, 14000 Caen, France; Department of Radiation Oncology, Dupuytren University Hospital, 2, avenue Martin-Luther-King, 87000 Limoges, France.
Summary
Radiotherapy plays a role in treating rare skin adnexal carcinomas. This review clarifies its use, dosage, and target volumes, addressing current uncertainties in treatment protocols for various subtypes.
Area of Science:
- Oncology
- Dermatology
- Radiation Oncology
Background:
- Skin adnexal carcinomas are rare malignancies originating from pilosebaceous, eccrine, and apocrine units.
- Current treatment often involves surgery and radiotherapy, but consensus on radiotherapy specifics is lacking for certain histologies.
Purpose of the Study:
- To review the current indications, optimal dose and fractionation, and target volumes for radiotherapy in skin adnexal carcinomas.
- To discuss ongoing research and address uncertainties in the management of these rare tumors.
Main Methods:
- Literature review of existing studies and guidelines on radiotherapy for skin adnexal carcinomas.
- Analysis of treatment parameters including indication, dose, fractionation, and irradiated volumes.
- Discussion of pathological subtypes and their impact on radiotherapy decisions.
Main Results:
- Radiotherapy indications and modalities vary significantly based on the pathological subtype of skin adnexal carcinoma.
- There is a lack of established consensus for specific histologies, highlighting the need for further research.
- The review synthesizes current knowledge on dose, fractionation, and volume considerations.
Conclusions:
- Radiotherapy is an important component in the multidisciplinary management of skin adnexal carcinomas.
- Further research and consensus-building are needed to optimize radiotherapy protocols for rare skin adnexal carcinomas.
- Standardizing treatment approaches will improve outcomes for patients with these rare cancers.
Related Concept Videos
Skin Cancer
4.3K
Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
4.3K
Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K

